Статья

Plasma hemostatic system in patients with the novel coronavirus disease 2019 (COVID-19)

M. Markelov, O. Beznoshchenko, T. Ivanets, A. Pyregov, R. Esayan, T. Gavrilova, L. Krechetova,
2020

Aim. To investigate plasma hemostasis in patients with different levels of COVID-19 severity. Materials and methods. The study included 46 patients with confirmed COVID-19, who were stratified into four groups based on disease severity as mild (1), moderate (2), severe (3), and critically severe (4). Laboratory investigations included APTT, Quick's prothrombin time, concentration of D-dimer, fibrinogen, ATIII, and platelet count. Results. D-dimer concentration >450 ng/ml was found in 100% of patients increasing from 973 (545–1635) ng/ml in group 1 to 13513 (7627–22512) ng/ml in group 4 (p

Цитирование

Похожие публикации

Источник

Версии

  • 1. Version of Record от 2020-01-01

Метаданные

Об авторах
  • M. Markelov
    Laboratory of Clinical Immunology
  • O. Beznoshchenko
    Laboratory of Clinical Immunology
  • T. Ivanets
    University Diagnostic Laboratory
  • A. Pyregov
    Institute of Anesthesiology, Reanimatology and Transfusiology
  • R. Esayan
  • T. Gavrilova
  • L. Krechetova
    Laboratory of Clinical Immunology
Название журнала
  • Akusherstvo i Ginekologiya (Russian Federation)
Том
  • 2020
Выпуск
  • 9
Страницы
  • 138-144
Номер гранта
  • undefined
Тип документа
  • journal article
Тип лицензии Creative Commons
  • CC BY
Правовой статус документа
  • Свободная лицензия
Источник
  • scopus